Profil
Claus Steensen Sølje is currently Director at Novo Nordisk Pharma Operations A since 2017.
Mr. Sølje is also Director at Sonion A. Since 2023, Mr. Sølje has been Chief Financial Officer & Executive Vice President at ALK-Abello A. Mr. Sølje graduated from the University of Copenhagen in 1999.
Postes actifs de Claus Steensen Sølje
| Sociétés | Poste | Début |
|---|---|---|
| ALK-ABELLÓ A/S | Directeur Financier/CFO | 01/06/2023 |
Novo Nordisk Pharma Operations AS
Novo Nordisk Pharma Operations AS Pharmaceuticals: OtherHealth Technology Engages in the pharmaceutical and medicine manufacturing industry | Directeur/Membre du Conseil | 25/04/2017 |
Sonion A/S
Sonion A/S Medical SpecialtiesHealth Technology Design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones | Directeur/Membre du Conseil | - |
Formation de Claus Steensen Sølje
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ALK-Abello A/S
ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sonion A/S
Sonion A/S Medical SpecialtiesHealth Technology Design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones | Health Technology |
Novo Nordisk Pharma Operations AS
Novo Nordisk Pharma Operations AS Pharmaceuticals: OtherHealth Technology Engages in the pharmaceutical and medicine manufacturing industry | Health Technology |
















